Literature DB >> 18077711

SIAH-1 interacts with the Kaposi's sarcoma-associated herpesvirus-encoded ORF45 protein and promotes its ubiquitylation and proteasomal degradation.

Rinat Abada1, Tsofia Dreyfuss-Grossman, Yifat Herman-Bachinsky, Haim Geva, Shiri-Rivka Masa, Ronit Sarid.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV), also referred to as human herpesvirus 8, is a potentially tumorigenic virus implicated in the etiology of Kaposi's sarcoma, primary effusion lymphoma, and some forms of multicentric Castleman's disease. The open reading frame 45 (ORF45) protein, encoded by the KSHV genome, is capable of inhibiting virus-dependent interferon induction and appears to be essential for both early and late stages of infection. In the present study, we show, both in yeast two-hybrid assays and in mammalian cells, that the ORF45 protein interacts with the cellular ubiquitin E3 ligase family designated seven in absentia homologue (SIAH). We provide evidence that SIAH-1 promotes the degradation of KSHV ORF45 through a RING domain-dependent mechanism and via the ubiquitin-proteasome system. Furthermore, our data indicate the involvement of SIAH-1 in the regulation of the expression of ORF45 in KSHV-infected cells. Since the availability of KSHV ORF45 is expected to influence the course of KSHV infection, our findings identify a novel biological role for SIAH proteins as modulators of virus infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077711      PMCID: PMC2258909          DOI: 10.1128/JVI.02285-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.

Authors:  A Depaux; F Regnier-Ricard; A Germani; N Varin-Blank
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 9.867

3.  Inhibition of ubiquitin ligase Siah-1A by disabled-1.

Authors:  Tae-Ju Park; Hiroki Hamanaka; Toshio Ohshima; Noriko Watanabe; Katsuhiko Mikoshiba; Nobuyuki Nukina
Journal:  Biochem Biophys Res Commun       Date:  2003-03-21       Impact factor: 3.575

4.  The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue.

Authors:  Ronen Ben-Saadon; Ifat Fajerman; Tamar Ziv; Ulf Hellman; Alan L Schwartz; Aaron Ciechanover
Journal:  J Biol Chem       Date:  2004-07-14       Impact factor: 5.157

5.  Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates beta-catenin activity in a p53-dependent manner.

Authors:  Akio Iwai; Hiroyuki Marusawa; Shu-ichi Matsuzawa; Toru Fukushima; Makoto Hijikata; John C Reed; Kunitada Shimotohno; Tsutomu Chiba
Journal:  Oncogene       Date:  2004-09-30       Impact factor: 9.867

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.

Authors:  Esti Liani; Allon Eyal; Eyal Avraham; Revital Shemer; Raymonde Szargel; Daniela Berg; Antje Bornemann; Olaf Riess; Christopher A Ross; Ruth Rott; Simone Engelender
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

8.  Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia.

Authors:  Koh Nakayama; Ian J Frew; Mette Hagensen; Marianne Skals; Hasem Habelhah; Anindita Bhoumik; Takayuki Kadoya; Hediye Erdjument-Bromage; Paul Tempst; Peter B Frappell; David D Bowtell; Ze'ev Ronai
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

9.  Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter.

Authors:  Giusy Fiucci; Séverine Beaucourt; Dominique Duflaut; Alexandra Lespagnol; Pamela Stumptner-Cuvelette; Anne Géant; Gilles Buchwalter; Marcel Tuynder; Laurent Susini; Jean-Michel Lassalle; Christine Wasylyk; Bohdan Wasylyk; Moshe Oren; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

10.  SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome.

Authors:  Julian P Venables; Caroline Dalgliesh; Maria Paolo Paronetto; Lindi Skitt; Jared K Thornton; Philippa T Saunders; Claudio Sette; Keith T Jones; David J Elliott
Journal:  Hum Mol Genet       Date:  2004-05-26       Impact factor: 6.150

View more
  13 in total

1.  Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation.

Authors:  Claus-Henning Nagel; Nina Albrecht; Kristijana Milovic-Holm; Lakshmikanth Mariyanna; Britta Keyser; Bettina Abel; Britta Weseloh; Thomas G Hofmann; Martha M Eibl; Joachim Hauber
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.

Authors:  Ersheng Kuang; Fayi Wu; Fanxiu Zhu
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

3.  Activation and degradation of open reading frame 45 by the replication and transcription activator of Kaposi's sarcoma-associated herpesvirus.

Authors:  Ying Wang; Kai Yu; Xiuzhi Pei; Tianzheng Zhang; Yuying Guo; Charles Wood; Jinzhong Wang
Journal:  J Gen Virol       Date:  2015-03-17       Impact factor: 3.891

4.  Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.

Authors:  H M Abdullah Al Masud; Takahiro Watanabe; Masahiro Yoshida; Yoshitaka Sato; Fumi Goshima; Hiroshi Kimura; Takayuki Murata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  The E3 Ubiquitin Ligase Siah-1 Suppresses Avian Reovirus Infection by Targeting p10 for Degradation.

Authors:  Xiang Chen; Zhiyuan He; Mengjiao Fu; Yongqiang Wang; Haiyang Wu; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.

Authors:  Heriberto Bruzzoni-Giovanelli; Plinio Fernandez; Lucía Veiga; Marie-Pierre Podgorniak; Darren J Powell; Marco M Candeias; Samia Mourah; Fabien Calvo; Mónica Marín
Journal:  J Exp Clin Cancer Res       Date:  2010-02-09

7.  Identification and characterization of two novel spliced genes located in the orf47-orf46-orf45 gene locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  Pey-Jium Chang; Chien-Hui Hung; Shie-Shan Wang; Ping-Hsin Tsai; Ying-Ju Shih; Li-Yu Chen; Hsiao-Yun Huang; Ling-Huei Wei; Ju-Bei Yen; Chun-Liang Lin; Lee-Wen Chen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

8.  Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein.

Authors:  Shir Bergson; Inna Kalt; Inbal Itzhak; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

9.  Identification of the nuclear export and adjacent nuclear localization signals for ORF45 of Kaposi's sarcoma-associated herpesvirus.

Authors:  Xiaojuan Li; Fanxiu Zhu
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

10.  Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.

Authors:  Dirk P Dittmer; Kristy L Richards; Blossom Damania
Journal:  Front Microbiol       Date:  2012-04-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.